RENAISSANCE - A multi-centre, non-interventional study of RElugolix as aNdrogen-deprivAtion therapy In patientS with advanced hormone-Sensitive prostate cANCErFirst published 22/03/2024 Last updated 22/03/2024 EU PAS number: EUPAS1000000077StudyPlanned